🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

RecruitingNAAges 40 Years - anyMaleUniversity of Sao Paulo
NCT07463092 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized, double-blind, placebo-controlled clinical trial will investigate the effects of creatine supplementation combined with a 12-week supervised resistance training program on muscle mass, muscle strength, physical performance (e.g., parameters of sarcopenia), and muscle density in men with prostate cancer undergoing androgen deprivation therapy (ADT). ADT often causes loss of lean mass, reduced muscle strength, functional impairment, and increased fat mass. Eligible male patients will be randomly assigned to receive either creatine monohydrate or a placebo (maltodextrin) in a double-blind manner, in addition to participating in the resistance exercise program. Assessments will be performed at baseline and after the 12-week intervention period and will include: * Muscle density and architecture assessed by ultrasound * Body composition (lean mass and fat mass) * Muscle stren

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Men aged ≥ 40 years; * Patients with histologically or cytologically confirmed localized prostate cancer; * Patients who have undergone surgical castration or pharmacological castration with gonadotropin-releasing hormone (GnRH/LHRH) agonists or antagonists for at least six months prior to the start of the intervention; * Patients receiving continuous or intermittent androgen deprivation therapy; * Patients with an Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2; * Not engaged in resistance training in the three months prior to the intervention; * Not using creatine supplementation in the three months prior to the intervention; * Willing to participate in a 12-week intervention consisting of resistance training performed three times per week and daily supplementation with creatine monohydrate or maltodextrin. Exclusion Criteria: * Patients with insulin-dependent diabetes mellitus; * Patients with dialysis-dependent renal failure; * Patients with severe chronic liver disease; * Estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73 m²; * Any hormonal treatment outside that established by the medical team; * Patients planning to undergo chemotherapy within the next six months.
💊

What it tests

  • Creatine Monohydrate
  • Maltodextrin
  • Resistance training
📍

Where

1 site
School of Physical Education and Sport - USP
São Paulo, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy